Artivion Secures FDA Approval for NEXUS Aortic System
ATLANTA, Georgia, United States, April 7, 2026 Artivion, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Cardiovascular
Advertisement
Bristol Myers Squibb Reports New Camzyos Data at ACC
PRINCETON, NEW JERSEY, March 23, 2026 Bristol Myers Squibb has unveiled new clinical and real-world data for Camzyos (mavacamten)...
CND Life Sciences’ Syn-One® Biomarker Services Advance Parkinson’s Research in Phase 2 Clinical Trial
PHOENIX, AZ – November 11, 2025 — CND Life Sciences, a pioneering neurodiagnostic company, announced that its Syn-One® Biomarker...
Cytokinetics Presents New MAPLE-HCM Data at AHA 2025, Strengthening Pipeline in Rare Cardiomyopathy Therapy
San Francisco, November 10, 2025 — Cytokinetics, Inc., a biopharmaceutical company focused on developing muscle biology–driven therapies, announced the...
Advertisement
